Related Experiment Video
Updated: May 22, 2026

06:18
Pioneering Patient-Specific Approaches for Precision Surgery Using Imaging and Virtual Reality
Published on: April 5, 2024
Advancements in Intraoperative Imaging for Enhanced Surgical Precision
Miles Pourbaghi1, Feng Chen1, Nabil Siddiqui1
1Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY, USA.
Summary
Cancer theranostics combined with advanced intraoperative imaging enable precise tumor removal, reducing residual disease. This integration of molecular targeting and AI-powered navigation improves surgical outcomes and patient prognosis in oncology.
Area of Science:
- Oncologic Surgery
- Medical Imaging
- Molecular Biology
Background:
- Targeted imaging agents and intraoperative guidance systems are transforming oncologic surgery.
- Precision tumor resection is crucial for reducing residual disease and improving patient outcomes.
Purpose of the Study:
- To examine the integration of cancer theranostics with advanced image-guided intraoperative imaging.
- To improve surgical precision, enhance targeted tissue removal, and spare vital structures.
Main Methods:
- Utilizing molecularly engineered probes (e.g., EGFR-targeted antibody, folate receptor alpha-targeting agent) for tumor margin delineation.
- Employing near-infrared (NIR) optical windows for enhanced sensitivity and spatial resolution.
- Integrating artificial intelligence (AI)-powered surgical navigation, multispectral cameras, and other advanced imaging systems.
Main Results:
- Molecular probes demonstrate high sensitivity and specificity in delineating tumor margins.
- Advanced imaging systems offer enhanced depth detection and dynamic visualization.
- AI and augmented reality refine image registration and quantitative analysis for actionable intraoperative feedback.
Conclusions:
- The synthesis of molecular targeting and advanced imaging addresses the need for complete tumor resection.
- Theranostic approaches show significant translational potential, advancing toward routine clinical practice.
- This integration represents a vital step forward in precision oncology, promising improved long-term patient outcomes.

